AUGUSTA, Ga., Feb. 20, 2023 (GLOBE NEWSWIRE) -- #" Accepting Best Lawyers Nominations Accepting Best Lawyers Nominations
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai 18-09-2024, 22:07